comparemela.com

Latest Breaking News On - Reset pharma - Page 1 : comparemela.com

Reset Pharma Receives Notice of Safe to Proceed from FDA for Investigational New Drug (IND) Application for Oral Psilocybin RSTP1000

Company may now initiate Phase 2b trial for treatment of demoralization syndrome in patients with cancerNEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development of innovative treatments to address mental health conditions related to life-altering diseases, today announces that the Company has received a Safe to Proceed notification from the U.S. Food and Drug Administration (FDA) regarding its Invest

EQS-News: Reset Pharmaceuticals, Inc : Reset Pharma Receives Notice of Safe to Proceed from FDA for Investigational New Drug (IND) Application for Oral Psilocybin RSTP1000

EQS-News: Reset Pharmaceuticals, Inc : Reset Pharma Receives Notice of Safe to Proceed from FDA for Investigational New Drug (IND) Application for Oral Psilocybin RSTP1000
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Filament Health take major step forward entering into licensing agreement with Reset Pharma

  Filament Health CEO Ben Lightburn joined Steve Darling from Proactive to announce a significant licensing agreement between Filament Health and Reset.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.